Cryo-Cell International (CCEL) Stock Analysis & Winston Score

Cryo-Cell International is a company that stores umbilical cord blood and cord tissue for families after a baby is born. The cord blood contains stem cells, which doctors can use to treat certain blood diseases and cancers later in life. Cryo-Cell is one of the oldest private cord blood banks in the United States, having operated since the early 1990s. The company makes money by charging families an upfront processing fee and then an annual storage fee to keep the samples frozen. It operates primarily in the United States but also licenses its technology to partners in other countries. Its long-term storage contracts and the difficulty of switching providers give it some customer stickiness, but the business faces real pressure from low awareness among new parents, competition from public cord blood banks, and thin operating margins that leave little room for error if enrollment growth slows.